Digital Technologies Transforming Bioprocessing

Discover the impact of AI on bioprocessing

Watch Now

Dr. Michael Sokolov

Founder & COO
DataHow AG

Overview

Join Dr. Michael Sokolov, COO of DataHow, as he explains what hybrid models are and how they are impacting process development and manufacturing with their AI and machine learning core and their ability to generate richer insights faster. He will explain how, with the right application, hybrid bioprocess models have far-reaching impacts from the lab to general business performance.

With this technology, new standards are being set in bioprocess development. Their ability to decipher insight from process data during development outperforms traditional methods and has far reaching impacts on how the biopharmaceutical industry approaches process development and the results which can be acheived.

In this webinar, key topics will include:

  • What is a hybrid model?
  • Why are they important in the lab, and for the business?
  • The impact: a case study review;
  • Are they applicable to your operation?
  • Key management outtakes.

This webinar will allow process development and manufacturing management to understand this emerging technology and its potential impact on their organisation.

Transforming digital
Bioprocessing